SCHEMBL30656223

SCHEMBL30656223

Cc1sc2ccc(OCc3ccccn3)cc2c1C(=O)NC1(CO)CCOCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 1/20 0.42
MMP3 P08254 2/20 0.40
MMP7 P09237 2/20 0.40
ADAMTS4 O75173 1/20 0.40
ADAM17 P78536 1/20 0.40
ADAMTS1 Q9UHI8 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
MAPK14 Q16539 6/20 0.40
SMO Q99835 3/20 0.40
CD274 Q9NZQ7 1/20 0.38
P2RY12 Q9H244 1/20 0.38
PRKDC P78527 2/20 0.38
MMP2 P08253 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
NPC1 O15118 1/20 0.36
HSP90AA1 P07900 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30656053 0.94 SMO (0.39) MAPK14SMONPC1HSP90AA1MAPT
SCHEMBL30656164 0.92 FGFR4 (0.41) MAPK14SMONPC1HSP90AA1MAPT
SCHEMBL30656008 0.92 MAPK14 (0.38) ADAM17MAPK14SMONPC1HSP90AA1
SCHEMBL30656232 0.88 KDM4E (0.43) BTKMMP3MMP7ADAMTS4ADAM17
SCHEMBL30656215 0.88 MAPK14 (0.39) MAPK14SMOP2RY12PRKDCMAOA
SCHEMBL30656274 0.87 ADAM17 (0.41) BTKMMP3MMP7ADAMTS4ADAM17
SCHEMBL30656046 0.85 CD274 (0.41) BTKMMP3MMP7ADAMTS4ADAM17
SCHEMBL30656068 0.85 MMP13 (0.42) BTKMMP3MMP7ADAMTS4ADAM17
SCHEMBL30656102 0.85 MMP3 (0.38) BTKMMP3MMP7ADAMTS4ADAM17
SCHEMBL24484791 0.84 CASP3 (0.46) BTKMMP3MMP7ADAMTS4ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP claimed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO claimed
EP-4532013-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS Katholieke Universiteit Leuven KU Leuven Research & Development (BE) 2025-04-09 EP disclosed
WO-2023227697-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed